Leadership of BSV Group - Bharat Serums and Vaccines Biopharmaceutical

Board of Directors

Bharat Serums & Vaccines Leadership - MD & CEO of BSV - Sanjiv Navangul

Sanjiv Navangul has led global pharmaceutical companies to success by mentoring and cultivating a values-driven culture. He has served on the board of Johnson & Johnson Pvt Ltd. India and Fulford India. He has held several leadership roles, including those of Managing Director for Janssen (Pharmaceutical Division of Johnson & Johnson) in India and South Asia; Managing Director for MSD Pharmaceuticals, Philippines; and Commercial Director for MSD India and South Asia. He served as the Vice President of OPPI (Organisation of Pharmaceutical Producers of India) from 2014 to 2019 and was Chairman of the AMCHAM Pharma committee (American Chamber of Commerce) from 2016 to 2019.

Under his leadership, BSV has been ranked 41st amongst Top Companies by AIOCD AWACS in Sept 2020 and one of the Top 10 Biopharma Companies in India (Biospectrum & ABLE).

In 2022, Sanjiv was awarded CEO of the Year at the 8th ILSC Awards. In 2021, he was honored with the Maharashtra Achievers Awards for his outstanding contribution to healthcare and pharma. And in 2020, he was recognized as one of Asia's top 25 healthcare technology CEOs by The Healthcare Technology CEOs of Asia. Sanjiv is a recipient of a number of industry awards on Public Health, Marketing and Diversity. Recently he was recognized as "Impactful CEO of the Year 2023" by The Economic Times.

Rajeev Juneja, MD and Vice Chairman of Mankind Pharma is a first-generation entrepreneur who dropped out of college in the pursuit of gaining practical experience in the pharmaceutical industry. Ever since, he describes himself as a student in the school of life. After spending 11 years understanding the intricacies and dynamics of the market, he started Mankind Pharma along with his elder brother, Shri Ramesh Juneja, in 1995.

29 years later, Mankind stands as India's premier pharmaceutical company in terms of prescriptions. Throughout this transformative period, Rajeev Juneja has passionately led diverse functional areas of business and in the process created a great balance between systems, processes and people within Mankind.

A believer in the power of simplicity, coupled with his distinctively imaginative and down-to-earth leadership style, and profound personal understanding of the customer’s needs has shaped the Mankind proposition in the market. Fueled by his heart and an unwavering commitment to fulfilling needs, Rajeev has seamlessly channeled his expertise across various organizational domains to formulate enduring, victorious strategies for the delivery of premium-quality pharmaceuticals. As a leader who recognizes the potential in each individual, he excels not only in building cross-functional teams that outperform global standards, but also in crafting and executing a compelling vision – to place Mankind Pharma among the top three companies with a strong market presence in OTC and FMCG segments.

Sheetal Arora, Chief Executive Officer of Mankind Pharma Ltd., is the visionary behind several innovative ideas and strategic decisions that have helped the company scale new heights. He is one of the trailblazers behind Mankind Pharma’s success who follows a simple ideology of 'reaching for the stars while staying firmly grounded,' which serves as an inspiration to the team of young, aspiring executives he leads.

His leadership has been a driving force in Mankind's expansion onto the global stage within the pharmaceutical industry. His strategy is to achieve the right blend of generic and niche products for global markets and nurture a team of professionals who can implement his vision.

Arjun Juneja joined Mankind Pharma Limited in 2009. He is a dedicated and accomplished business leader with a career spanning over a decade in the pharmaceutical industry. As the Chief Operating Officer at Mankind, he oversees critical areas of the business, including Research & Development, Manufacturing, Supply Chain, Quality Assessment, Information Technology & Digitization and Active Ingredients, among others.

A second-generation leader, he embodies a commitment to innovation and the relentless pursuit of new horizons. His visionary thinking and adaptability to change have been instrumental in propelling the Company to unprecedented success. Under his leadership, Mankind has achieved several milestones in the field of Operational Excellence in its Manufacturing Processes. He also led the successful listing of Mankind during the year 2023. Mankind’s IPO was the largest IPO of the calendar year 2023.

Arjun Juneja boldly expanded Mankind's reach into the US market, implementing an aggressive pricing strategy to establish the Company among India's top-tier generic pharmaceutical firms. His strategic vision has also led the Company into regulated markets, culminating in the attainment of USFDA approvals, a testament to the unwavering pursuit of the Company's vision.

Executive Committee

Sanjiv Navangul has led global pharmaceutical companies to success by mentoring and cultivating a values-driven culture. He has served on the board of Johnson & Johnson Pvt Ltd. India and Fulford India. He has held several leadership roles, including those of Managing Director for Janssen (Pharmaceutical Division of Johnson & Johnson) in India and South Asia; Managing Director for MSD Pharmaceuticals, Philippines; and Commercial Director for MSD India and South Asia. He served as the Vice President of OPPI (Organisation of Pharmaceutical Producers of India) from 2014 to 2019 and was Chairman of the AMCHAM Pharma committee (American Chamber of Commerce) from 2016 to 2019.

Under his leadership, BSV has been ranked 41st amongst Top Companies by AIOCD AWACS in Sept 2020 and one of the Top 10 Biopharma Companies in India (Biospectrum & ABLE).

In 2022, Sanjiv was awarded CEO of the Year at the 8th ILSC Awards. In 2021, he was honored with the Maharashtra Achievers Awards for his outstanding contribution to healthcare and pharma. And in 2020, he was recognized as one of Asia's top 25 healthcare technology CEOs by The Healthcare Technology CEOs of Asia. Sanjiv is a recipient of a number of industry awards on Public Health, Marketing and Diversity. Recently he was recognized as "Impactful CEO of the Year 2023" by The Economic Times.

Rahul Adakmol - COO, International Operations - BSV

Rahul Adakmol is a visionary leader with over 15 years of experience in specialty drugs, P&L management, BD, and licensing.

He brings a pioneering perspective to our commercial and business operations subsidiaries in Germany and the Philippines, as well as our global BD and M&A.

Alok Khettry - COO, India Business of BSV

Alok is a seasoned sales professional and a versatile leader with diverse leadership experience of over three decades. He has been serving the industry as a growth catalyst and is recognized for his agility to adapt business models in response to market demands. Alok has a proven track record of successful collaboration with multiple stakeholders and key decision makers. He has managed multiple countries & multi-cultural Global/Regional teams in Pharmaceutical/ Biotechnology industry with P&L responsibility for India, Malaysia, Singapore, Brunei, Sri Lanka and Nepal. Prior to BSV, Alok has held leadership positions in esteemed pharmaceutical organizations such as Cadila and Sanofi. Alok is passionate about developing talent and inspiring teams to perform by creating a culture of coaching and mentorship.

Past Experience :

President, Cadila Pharmaceuticals India
Head, Established Products Business Unit, Multi-Country Organization, Sanofi

Education :

Strategic Marketing, Indian School of Business
MBA (Marketing), Institute of Management Studies, University of Indore
MBA (Finance), Institute of Management Studies, University of Indore
B Sc. Physics, Mathematics, Statistics- Lucknow University

Key Skills :

Collaborative Leadership
People Development
Change and Culture Management

Vishwanath Swarup - Chief Operating Officer of BSV

Vishwanath held numerous leadership positions with companies before joining BSV, including Dr. Reddy's Laboratories, Abbott, and Max Bupa.

Vishwanath Swarup is a results-oriented leader with fast-paced business skills. His experience in operations, strategic planning, corporate development, and sales management makes him a key leader of our team. His dedicated efforts have helped BSV bag multiple awards, including ‘Outstanding Technology Product or Service for BSVwithU’ by Quantic twice in 2022, ‘AntiD’ being recognized as one of the ‘Best Healthcare brands 2022' by ET. Further, the ‘Gold Impact’ award for the Brand Amphonex by Pronto Consult in 2022, Team Fertility awarded by Radiocity for ‘Excellence in IVF Led Awareness & Treatments in Healthcare’ in 2022, 'Most Innovative brand launch in biopharmaceutical - AG Cuffill' and 'Best Work in Animal Bite Management' by CIMS Medica, IPC, Dept. of Pharmaceuticals - Ministry of Chemicals and Fertilizers, Ministry of MSME in 2022.

Other awards include - 'Pharma Excellence Award' (Express Pharma & Health Foundation Aug 2020), ‘Fastest Growing Indian Biotech Company’ (Frost & Sullivan 2012 & 2013), Brand Excellence Awards (ABP News), 'Brand Excellence Award' in Biotech Sector by World Marketing Congress, BSV recognized for 'Maximum Doctor’s Pledge to support breastfeeding Awareness Initiative' by India Book of Records in 2022, and ‘Veeva Team Hero’ award for implementing Veeva Vault PromoMats in less than seven weeks during the pandemic in 2021.

His achievements include being recognized as One of the '100 Inspirational Leaders of Asia', 2022, by White Pages International.

Dr. Jaby Jacob - Sr President of Research & Development of BSV

Dr. Jaby Jacob has worked at several large companies, including Kemwell Biopharma, Dr. Reddy’s and AMGEN before joining BSV.

He is an active participant in the development of several biopharmaceutical products, including monoclonal antibodies. He has over two decades of experience in developing biosimilar drug strategies for both regulated and emerging markets, including process characterization, analytical development and validation, and technology transfer management.

BSV Chief Human Resources Operations - Nilesh Kulkarni

Nilesh Kulkarni is a seasoned human resources leader with over two decades of experience in L&D, recruitment, mergers and acquisitions, organization design, succession, and talent management. He has held various leadership positions in India, South Asia, and Switzerland. From being an organization driven by function, Nilesh is instrumental in making BSV an organization that’s driven by talent. His acumen has helped BSV get recognized as ‘Best Organization for Women’ by The Economic Times in 2022, ‘Best Sustainable Business Organisation’ by ET Edge in 2022, and ‘Dream Companies to Work For’ by the World HRD Congress-Feb 2019.

Chief Financial Officer - Chirag Mehta - Bharat Serums & Vaccines

Chirag has previously worked with Cipla, Maneesh Pharma, and Intas Pharmaceuticals.

Chirag Mehta brings over two decades of experience in Finance and Operations Management, including Corporate Accounting, National Pharmaceutical Pricing Authority (NPPA), Commercial, Legal, and Central Data Management. His experience and willingness to help and motivate others has been instrumental in the success we’ve had since he joined.

He was most recently recognized by CEO Insights as one of the Top 10 CFOs of 2022.

Anjan Ghosh - Sr President, Commercial Excellence - Bharat Serums & Vaccines

Anjan Ghosh brings a wealth of experience in Operations and Strategy. He brings over 3 decades of experience in the APAC (including Japan, Australia, and New Zealand) region, having worked in different roles and responsibilities like P&L management, SFE, and managing mergers and integrations of organizations. His strategic thinking combined with his deep industry knowledge makes him an ideal member of the BSV team as it evolves in this rapidly changing landscape.

His immense contribution has led BSV to earn four awards in 2022, including – ‘Innovation in Learning’ & ‘Business impact through Learning and Development’ at the 8th Edition Future of Work Summit and Awards 2022 and ‘Outstanding Achievement in Digital Pharma Marketing’ & ‘Outstanding Achievement in Digital Pharma Marketing for L&D Team’ at Digipharmax.

Dr. Swashraya Shah - Chief Medical Officer of BSV

Dr. Swashraya Shah has a strong background in the medical field, with a track record of success in strategic planning, team development, coaching, medico-marketing, clinical research, and regulatory sciences. A seasoned medical professional, he is skilled in identifying key challenges and implementing innovative solutions that have resulted in measurable growth and positive outcomes for companies he has worked with over the years.

Owing to his impeccable efforts BSV is ranked among the 10 Most Trusted Vaccine
Solution Providers 2020 (CIOLook Magazine).

Anil Damle - Sr. President, Corporate Projects & Supply Chains of BSV

Anil Damle has over 30 years of experience in Treasury and Risk Management, Statutory/Internal/Forensic/SOX audits, and Compliance Execution and Training. In particular, he has a strong understanding of treasury operations in a complex global environment with multiple regulatory regimes.

His contribution has helped BSV win multiple accolades, which include – ‘Best Pharma Distribution Network Strategy’ (TATA Strategic Management Group & CNBC TV18, Feb 2018), ‘Best In-Class Distribution Network Strategy’ award at the Future Supply Chain (7th Cold Chain Strategy Summit, June 2018), and ‘Best Procurement Company of the Year’ Award (IPLA 2022).

Resham-Bagaria-Sr-General-Manager-Transformation-Office-bsv

Resham Bagaria has over eight years of management consulting experience with leading projects across corporate strategy, investment advisory and sustainability in different domains and industries.

Prior to BSV, she has had consulting stints with Bain & Company, cKinetics and The Smart Cube. She has strategy and finance education background with Bachelors from Shri Ram College of Commerce, MBA from IIM Lucknow and CFA Level 3.

Leadership

Leadership

Board of Directors

MD & CEO

Sanjiv Navangul

Director

Rajeev Juneja

Director

Sheetal Arora

Director

Arjun Juneja

Executive Committee

MD & CEO

Sanjiv Navangul

COO- International Operations and Business Development

Rahul Adakmol

Chief Operating Officer - India Business

Alok Khettry

Chief Operating Officer

Vishwanath Swarup

Sr. President - R&D

Dr Jaby Jacob

Chief Human Resources Officer

Nilesh Kulkarni

Chief Financial Officer

Chirag Mehta

Sr. President - Commercial Excellence and Strategy

Anjan Ghosh

Chief Medical Officer

Dr Swashraya Shah

Sr. President - Corporate Projects and Supply Chain

Anil Damle

Sr. General Manager - Transformation Office

Resham Bagaria

Sustainability and Corporate Social Responsibility Committee

Risk Management Committee

Locate us

India

Philippines

Malaysia

Germany